🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7923548

Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-n

The Board of Regents of the University of Texas System · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7923014

Expression and purification of HIP/PAP and uses therefor

The Board of Regents of the University of Texas System · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919613

RNAi modulation of SCAP and therapeutic uses thereof

The Board of Regents of the University of Texas System · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919579

Imaging and therapeutic targeting of prostate and bladder tissues

The Board of Regents of the University of Texas System · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915245

Methods and compositions of trail-death receptor agonists/activators

The Board of Regents of the University of Texas System · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7914780

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906628

Targeting proteins to deliver therapeutic or diagnostic reagents

The Board of Regents of the University of Texas System · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7897340

Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker

The Board of Regents of the University of Texas System · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7893033

Targeting proteins to deliver therapeutic or diagnostic reagents

The Board of Regents of the University of Texas System · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892567

Methods and compositions for immunization against chlamydial infection and disease

The Board of Regents of the University of Texas System · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887836

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884211

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879801

Compositions comprising cell-impermeant duramycin derivatives

The Board of Regents of the University of Texas System · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871775

Compositions and methods for the identification, assessment, prevention and therapy of hum

The Board of Regents of the University of Texas System · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863275

Uses of tetrahydrobiopterin and derivatives thereof

The Board of Regents of the University of Texas System · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863414

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

The Board of Regents of the University of Texas System · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858592

Interfering RNAs against the promoter region of P53

The Board of Regents of the University of Texas System · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7854932

Immunogenic compositions comprising progastrin and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7847084

VMP-like sequences of pathogenic Borrelia species and strains

The Board of Regents of the University of Texas System · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838556

Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligan

The Board of Regents of the University of Texas System · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838691

Palmerolides: methods of preparation and derivatives thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838511

Compositions and methods for treating, preventing and/or ameliorating cancers, the onset o

The Board of Regents of the University of Texas System · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7829688

Peptides of CaV2.2 that inhibit pain

The Board of Regents of the University of Texas System · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7829668

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted